A50.SI SES
Thomson Medical Group Limited
1W: -3.9%
1M: -5.7%
3M: -5.7%
YTD: -18.0%
1Y: +2.0%
3Y: -10.0%
5Y: -41.8%
S$0.05 ($0.04)
+0.00 (+0.00%)
Weekly Expected Move ±2.9%
S$0
S$0
S$0
S$0
S$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$395M
+12.4% ▲
5Y CAGR: +12.8%
Gross Profit
$295M
+7.2% ▲
5Y CAGR: +23.9%
Operating Income
$16M
-78.4% ▼
Net Income
-$48M
-436.1% ▼
EPS (Diluted)
$-0.00
-460.0% ▼
EBITDA
$58M
-47.1% ▼
5Y CAGR: +4.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $240M | $334M | $356M | $351M | $395M |
| YoY Growth | +11.2% | +38.8% | +6.6% | -1.3% | +12.4% |
| Cost of Revenue | $124M | $55M | $59M | $76M | $99M |
| Gross Profit | $116M | $278M | $296M | $275M | $295M |
| Gross Margin | 48.3% | 83.4% | 83.3% | 78.4% | 74.8% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | -$80K | -$24K | $0 |
| Operating Expenses | $67M | $187M | $214M | $202M | $279M |
| Operating Income | $49M | $92M | $82M | $74M | $16M |
| Operating Margin | 20.3% | 27.5% | 23.1% | 20.9% | 4.0% |
| Interest Expense | $24M | $23M | $31M | $52M | $60M |
| Income Before Tax | $26M | $69M | $55M | $29M | -$41M |
| Tax Expense | $9M | $11M | $14M | $11M | $6M |
| Net Income | $14M | $54M | $37M | $14M | -$48M |
| Net Margin | 5.9% | 16.1% | 10.3% | 4.0% | -12.1% |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $-0.00 |
| EBITDA | $60M | $111M | $107M | $109M | $58M |
| Shares Outstanding | 26.44B | 26.44B | 26.45B | 26.46B | 26.46B |